Navigation Links
Plasma in bags
Date:11/11/2011

Physicians are increasingly using live cells in their treatments: in blood transfusions and bone marrow transplants, as well as in stem cell therapies and following severe burns. Cells taken from the patients themselves are ideal for replacing burned skin, eliminating immune deficiencies, repairing degenerated cartilage or to treat injured bones as they are not rejected by the immune system. These cells have to be kept, cultivated, reproduced or even modified in a patient-specific manner. The problem, however, lies in the storability of the cell solutions used. As they can easily become infected by germs, they can only be stored for a few days in the containers conventionally used today. The joint project InnoSurf aims to remedy this problem: scientists from five research institutions, along with partners in the industry have developed innovative plastic surfaces and measuring methods for efficiently producing human cells for diagnostic and therapeutic applications. The work was coordinated by the Helmholz Centre for Infection Research (HZI) in Braunschweig, Germany.

The idea is to cultivate the cells in sealed, sterile plastic bags. The inner surface of the bags has to be modified so that they provide cells with good conditions for survival. A team led by Dr. Michael Thomas at the Fraunhofer Institute for Surface Engineering and Thin Films IST in Braunschweig, Germany, has now developed a plasma technology process for use at atmospheric pressure. "We fill the bags with a specific gas mixture and apply an electrical voltage" explains scientific assistant Dr. Kristina Lachmann. "Inside them, for a brief period, plasma is created, i.e. a luminescent, ionized gas, which chemically alters the plastic surface". During this process the bag remains sterile as plasmas also have a disinfecting action. "The advantage of the process is that it operates at atmospheric pressure and is therefore cost-effective, fast and flexible" emphasizes group leader Dr. Michael Thomas who specializes in the use of such atmospheric pressure plasmas to modify surfaces.

The new bags facilitate the sterile handling of cell cultures. Previously, researchers and clinicians had to use open Petri dishes, bottles or bioreactors. As these systems need to be opened, at least for filling, contamination can easily occur. By contrast, when using the new technology with its sealed bag system, the cells migrate directly into the bag via an injection needle or connected tube systems without coming into contact with their surroundings. The sterile interior of the bags contains nutrient medium and germ-free air or a suitable gas, which been added beforehand. Even during the cultivation period the containers do not have to be opened, and at the end the cells can be removed again by injection needle.

The researchers also maybe intend to use the disposable systems for growing artificial organs. If the bags are provided with a three-dimensional structure, cells could attach themselves to it and create artificial skin, nerves, cartilage or bone which could be used prosthetically in the patient. So far their cultivation has mainly failed because the stem cells have been reluctant to attach themselves to spatial structures. The plasma process developed at the IST could solve this problem. In collaboration with the University of Tbingen, Braunschweig City Hospital plans to isolate certain stem cells from tissue samples and investigate on which of the new plastic surfaces they could develop into bone or cartilage, for example. For this development by the group led by Dr. Michael Thomas, the IST was awarded "Selected Location 2011" as part of the "Land of Ideas" initiative. The prize will be awarded at the IST in Braunschweig on December 8, 2011.


'/>"/>
Contact: Dr. Michael Thomas
michael.thomas@ist.fraunhofer.de
49-531-215-5525
Fraunhofer-Gesellschaft
Source:Eurekalert  

Related biology news :

1. RevaTen platelet-rich plasma shows promise as potential treatment for heart attacks
2. MIT researchers study the danger of toxoplasma parasites
3. Scripps Research scientists redefine the role of plasma cells in the immune system
4. Grant advances quark-gluon plasma studies

5. Atmospheric pressure plasma jet from a grounded electrode
6. Toxoplasma gondii spreads in the habitat of the Iberian lynx
7. Modeling Toxoplasma focus of workshop
8. Plasma produces KO cocktail for MRSA
9. How Toxoplasma gondii gets noticed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plasma in bags
(Date:3/22/2017)... , March 21, 2017 Vigilant Solutions ... serving law enforcement agencies, announced today the appointment of ... director of public safety business development. Mr. ... enforcement experience, including a focus on the aviation transportation ... most recent position, Mr. Sheridan served as the Aviation ...
(Date:3/16/2017)... , March 16, 2017 CeBIT 2017 - Against identity fraud ... Continue Reading ... Used combined in one project, multi-biometric solutions provide a ... Used combined ... ...
(Date:3/9/2017)... VIEW, Calif. , March 9, 2017 ... 23andMe , the leading personal genetics company, are using ... now provide customers with personalized nutrition plans that consider ... but also genetic markers impacting how their body may ... food decision support platform uses biometrics such as Body ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... March 22, 2017 , ... Researchers face a fundamental challenge ... to full-size tissues, bones, even whole organs to implant in people to treat ... deep into the developing tissue. , Current bioengineering techniques, including 3-D printing, ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)... TORONTO , March 22, 2017 /PRNewswire/ - ... Therapeutics (the "Company" or "Propellon"), a start-up created ... WDR5-targeted anti-cancer therapeutics. FACIT,s investment, combined with non-dilutive ... lead program. The seed funding enables Propellon to ... position the Company for financing and/or entering a ...
(Date:3/22/2017)... ... ... Okyanos Cell Therapy has announced Tallahassee, FL will be the next destination ... Therapy: The Next Phase in the Evolution of Medicine.” As the Bahamas’ first fully ... Act, Okyanos maintains a mission to help “no-option” patients and those with serious, ...
Breaking Biology Technology: